US Stock MarketDetailed Quotes
SWTX SpringWorks Therapeutics
- 41.730
- +0.510+1.24%
Close Nov 27 16:00 ET
- 41.730
- 0.0000.00%
Post 20:02 ET
3.10BMarket Cap-10727P/E (TTM)
42.380High40.995Low682.25KVolume41.470Open41.220Pre Close28.49MTurnover0.99%Turnover RatioLossP/E (Static)74.39MShares53.92052wk High5.83P/B2.88BFloat Cap28.21052wk Low--Dividend TTM69.09MShs Float96.480Historical High--Div YieldTTM3.36%Amplitude13.600Historical Low41.761Avg Price1Lot Size
About SpringWorks Therapeutics Company
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.
Company Profile
SymbolSWTX
Company NameSpringWorks Therapeutics
Listing DateSep 13, 2019
Issue Price18.00
Founded2017
CEOMr. Saqib Islam, J.D.
MarketNASDAQ
Employees305
Fiscal Year Ends12-31
Address100 Washington Boulevard
CityStamford
ProvinceConnecticut
CountryUnited States of America
Zip Code06902
Phone1-203-883-9490
Websitehttp://www.springworkstx.com
Company Executives
- Name
- Position
- Salary
- Saqib Islam, J.D.
- Director and Chief Executive Officer
- 18.35M
- Dr. Badreddin Edris, PhD
- Chief Operating Officer
- 6.64M
- Tai-An Lin
- Chief Scientific Officer
- --
- Francis I. Perier, Jr
- Chief Financial Officer
- 3.74M
- Daniel Pichl
- Chief People Officer
- --
- Bhavesh Ashar, M.B.A.
- Chief Commercial Officer
- --
- Dr. James Cassidy, M.D.,PhD
- Chief Medical Officer
- 4.31M
- Michael Nofi
- Chief Accounting Officer
- --
- Daniel S. Lynch, M.B.A.
- Chairman of the Board
- 545.14K
- Carlos Alban
- Independent Director
- 507.64K
- Alan Fuhrman
- Independent Director
- 520.14K
- Dr. Julie Hambleton, M.D.
- Independent Director
- 520.14K
- Dr. Martin W. Mackay, PhD
- Independent Director
- --
- Dr. Freda C. Lewis-Hall,M.D.
- Independent Director
- 508.45K
- Herschel S. Weinstein, J.D.
- General Counsel and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data